Yudong Cao

6PUBLICATIONS
4CO-AUTHORS
Predictive and prognostic markersCancer cell biologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 15, 2026
Post-Treatment NLR and SII Associations with Response and Progression-Free Survival After Neoadjuvant Disitamab Vedotin Plus PD-1 Blockade in Muscle-Invasive Bladder Cancer: A Real-World Cohort Study.

|Sep 15, 2026
Cancer Cachexia in Advanced Renal Cell Carcinoma: From Molecular Mechanisms to Prognostic Assessment.

|May 04, 2026
HCN2 Promotes BGN Transcription via REST to Regulate Ferroptosis and Tumor Progression in Bladder Cancer.

|Nov 13, 2025
The Association of HER-2 Expression with Clinicopathological Characteristics and Clinical Outcomes in Patients with Localized Prostate Cancer After Radical Prostatectomy.

Shuo Wang, Ruijian You, Xiao Yang

|Jul 23, 2025
TNF Signaling Pathway Is the Key Pathway Regulated by Disitamab Vedotin in Bladder Cancer Cells.

Xingxing Tang, Jia Liu, Qiang Zhao

|Apr 14, 2025
Comparing the long-term prognosis and renal function changes of partial nephrectomy (PN) and radical nephrectomy (RN) in T1 stage renal cell carcinoma patients.

Yudong Cao, Yushuang Cui, Ruojing Li

Pageof 1

Frequent Collaborators

2 joint publications

Xingxing Tang

1 joint publications

Yushuang Cui

1 joint publications

Yongsheng Huang

1 joint publications

Yongjie Li